financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Comerica Incorporated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Comerica Incorporated
Apr 18, 2024 7:21 AM

09:50 AM EDT, 04/18/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our target price by $1 to $41, 6.9x our 2025 EPS estimate, a discount to CMA's five-year forward P/E average of 11.3x given weak net interest income expectations. We decrease our 2024 EPS estimate by $0.36 to $5.25 and reduce 2025's by $0.06 to $5.93. CMA posted Q1 EPS of $1.29 versus $2.39 a year ago, $0.14 above consensus. Net interest income fell 6% Q/Q as the bank saw its net interest margin contract 11 bps to 2.80%. Weakness was identified in noninterest-bearing deposits (-5%), although management indicated that balances have neared a trough. We view this prediction as a bit optimistic and expect CMA to continue to see moderate outflows as clients are enticed with higher interest-bearing accounts. Loan growth (-3%) underperformed peers as commercial loan balances dipped 6%. Improvement was seen in the bank's capital profile (CET1 ratio +40 bps to 11.5%), although large unrealized losses in the bank's securities portfolio will likely keep the bank away from buybacks in the near term.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Mar 24, 2025
01:35 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our USD8 target (2x 2025 P/B) and Strong Sell rating on XPeng ( XPEV ). The company reported 2024 revenue growth of 33.2% to CNY40.87B, with gross margin...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Mar 24, 2025
02:15 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $16 to $216, 20x (from 19x) our FY 26 (May) EPS of $10.83 (from $10.50) and in line with its three-year historical average forward...
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Mar 24, 2025
03:25 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month price target of $19 is based on 15.2x our FY 26 (Mar.) EPS estimate and in line with the company's three-year average forward P/E multiple of...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Mar 24, 2025
04:45 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $331 from $304 based on our Net Present Value (NPV) analysis. We lower our 2025 EPS estimate to -$1.62 from $0.30 our 2026 EPS...
Copyright 2023-2025 - www.financetom.com All Rights Reserved